Validation of the Severe-Respiratory-Insufficiency Questionnaire (SRI) for COPD patients receiving long-term oxygen therapy

• Conditions: J44.81; J96.10; J96.11

• Registration Number: DRKS00006067
• Lead Sponsor: niversitätsklinik FreiburgAbt. Pneumologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2012-12-12
• Study Start: 2014-04-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 145

Inclusion Criteria

COPD patients with established (at least 1 month) NIV or LTOT-therapy, respectively.

Exclusion Criteria

LTOT and/or NIV as treatment of other chronic pulmonary or ventialtory diseases
Exacerbations within the last 4 weeks
Malignancies
Language comprehension disorders

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary endpoint is the assessment of reliability of the SRI questionnaire for the LTOT group using the cronbach's alpha.

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints are differences in the SRI sum scale or subscales between the LTOT and NIV groups.